Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
03/07/2012 | CN102369185A Indole derivatives for treating neurodegenerative diseases |
03/07/2012 | CN102369015A Peptides, pharmaceutical compositions comprising same and uses thereof |
03/07/2012 | CN102367277A Polymer conjugates of mutated neublastin |
03/07/2012 | CN102366631A Application of recombinant adeno-associated virus (AAV) expressing BDNF-HA2TAT in preparing medicaments treating depression diseases |
03/07/2012 | CN102366620A Traditional Chinese medicine preparation for treating epilepsy |
03/07/2012 | CN102366619A Medicine for treating abnormal menstruation caused by asthenia of qi and blood and insomnia |
03/07/2012 | CN102366604A Sobering traditional Chinese medicinal preparation and its preparation method |
03/07/2012 | CN102366601A Traditional Chinese medicine preparation for treating apoplexia, facial paralysis and hemiplegia |
03/07/2012 | CN102366597A Traditional Chinese medicine preparation for prevention and treatment of nervous depression |
03/07/2012 | CN102366586A Chinese herbal medicine for treating kidney deficiency, spleen dampness and headache |
03/07/2012 | CN102366585A Chinese herbal medicine for treating headache caused by yin deficiency of liver and kidney, hyperactivity of liver-yang and stagnation of spleen |
03/07/2012 | CN102366563A Chinese herbal medicine for treating yin-deficiency liver-hyperactivity sleeplessness |
03/07/2012 | CN102366562A Chinese herbal medicine for treating spleen deficiency, gastric stasis and insomnia |
03/07/2012 | CN102366558A Reagent for relieving heat toxin |
03/07/2012 | CN102366556A Medicine for treating cerebral embolism sequela and preparation method thereof |
03/07/2012 | CN102366555A Chinese medicine prescription for treating epilepsy |
03/07/2012 | CN102366553A Chinese medicine formula for treating angioneurotic headache |
03/07/2012 | CN102366552A Traditional Chinese medicine composition for treating angioneurotic headache |
03/07/2012 | CN102366529A Traditional Chinese medicine for treating neurodermatitis |
03/07/2012 | CN102366523A Chinese herbal medicine for treating yin deficiency, qi stagnation and hygropyretic headache |
03/07/2012 | CN102366511A Method of preparing medicine for activating dormant cerebral nerves |
03/07/2012 | CN102366501A Self-heated traditional Chinese medicine (TCM) emplastrum for improving sleep quality |
03/07/2012 | CN102366475A Traditional Chinese medicine for treating deficiency of qi and blood and insomnia |
03/07/2012 | CN102366470A Traditional Chinese medicinal preparation for treating Parkinsonism |
03/07/2012 | CN102366456A Chinese patent medicine for treating angioneurotic headache |
03/07/2012 | CN102366452A Traditional Chinese medicine preparation for treating insomnia, forgetfulness, deficiency of spleen and stomach, and its preparation method |
03/07/2012 | CN102366408A Monosialotetrahexosyl ganglioside sodium liposome injection |
03/07/2012 | CN102366402A Scopolamine hydrobromide injection and production technology |
03/07/2012 | CN102366275A Chinese herb pillow |
03/07/2012 | CN102058787B Anxiolytic drug and preparation method thereof |
03/07/2012 | CN102010454B Citicoline sodium compound and new method thereof |
03/07/2012 | CN101966172B New purpose of caffeic acid and derivatives thereof |
03/07/2012 | CN101766626B Blonanserin-contained oral preparation for treating schizophrenia |
03/07/2012 | CN101698649B Short-acting hypnotizing and calming compound used for anesthetization |
03/07/2012 | CN101626764B Amino acid composition |
03/07/2012 | CN101559201B Traditional Chinese medicine for treating epilepsy |
03/07/2012 | CN101536979B Edaravone lipid microsphere formulation and preparation method |
03/07/2012 | CN101381339B Prodrugs of gaba analogs, compositions and uses thereof |
03/07/2012 | CN101306146B Hog compression drug for treating trigeminal neuralgia |
03/07/2012 | CN101287730B Glucuronate salt of a piperazine compound |
03/07/2012 | CN101198320B Herpesvirus-derived therapeutic agent for pain |
03/06/2012 | US8129545 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
03/06/2012 | US8129537 Compounds as PDE IV and TNF inhibitors |
03/06/2012 | US8129535 Alkyl ether derivatives or salts thereof |
03/06/2012 | US8129418 Macrocyclic compounds and methods of treatment |
03/06/2012 | US8129402 Screening molecules with anti-prion activity: kits, methods and screened molecules |
03/06/2012 | US8129397 Substituted thieno[2,3-d]pyrimidines as AMPA modulators |
03/06/2012 | US8129381 Caspase inhibitors and uses thereof |
03/06/2012 | US8129378 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer |
03/06/2012 | US8129373 Carbonyl compounds |
03/06/2012 | US8129370 Use of oxicam compounds |
03/06/2012 | US8129360 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids |
03/06/2012 | US8129354 Alzheimer's, Parkinson's, multiple sclerosis, schizophrenia, epilepsy, depression and pain |
03/06/2012 | US8129332 Reagents and methods for smooth muscle therapies |
03/06/2012 | US8129112 Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications |
03/06/2012 | CA2604017C Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
03/06/2012 | CA2550892C Spirocyclic cyclohexane derivatives |
03/06/2012 | CA2543308C Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders |
03/06/2012 | CA2513088C Deuterated catecholamine derivatives and medicaments comprising said compounds |
03/06/2012 | CA2487734C Treatment with cytokines for alzheimer's disease |
03/06/2012 | CA2486055C Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
03/06/2012 | CA2485532C Process for the preparation of 2-methyl piperazine derivatives |
03/06/2012 | CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
03/06/2012 | CA2452881C Novel bicyclic and tricyclic cannabinoids |
03/06/2012 | CA2446550C Abuse-resistant controlled-release opioid dosage form |
03/06/2012 | CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries |
03/06/2012 | CA2434831C Polypeptide drug substances |
03/06/2012 | CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
03/01/2012 | WO2012027611A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
03/01/2012 | WO2012027570A2 Dual variable domain immunoglobulins and uses thereof |
03/01/2012 | WO2012027326A2 Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin |
03/01/2012 | WO2012026903A1 Synergistic compositions comprising memantine and gingko - biloba extract |
03/01/2012 | WO2012026665A1 Novel tacrolimus derivatives, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same |
03/01/2012 | WO2012026662A1 Composition including undecylenic acid and/or conjugated linoleic acid for the prevention and treatment of degenerative neurological disorders |
03/01/2012 | WO2012026641A1 Composition for preventing or treating dementia |
03/01/2012 | WO2012025877A1 Proline sulfonamide derivatives as orexin receptor antagonists |
03/01/2012 | WO2012025677A1 Inhalable gaseous drug containing krypton for treating neuro-intoxication |
03/01/2012 | WO2012025609A1 Plant extracts made of sideritis and use thereof to boost cognitive performance |
03/01/2012 | WO2012025239A1 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators |
03/01/2012 | WO2012025238A1 Substituted quinoline-3-carboxamides as kcnq2/3 modulators |
03/01/2012 | WO2012025237A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
03/01/2012 | WO2012025236A1 Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
03/01/2012 | WO2012025217A1 Novel use of leflunomide and malononitrilamides |
03/01/2012 | WO2012025123A1 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine |
03/01/2012 | WO2012024893A1 Certain chemical entities, compositions, and methods |
03/01/2012 | WO2012024772A1 Protein-bound tryptophan food composition |
03/01/2012 | WO2012004714A3 Benzene sulfonamides as inhibitors of voltage-gated sodium channels |
03/01/2012 | WO2012004706A3 Chemical compounds |
03/01/2012 | WO2011161537A3 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
03/01/2012 | WO2011143400A3 Method and composition for inducing human pluripotent stem cells |
03/01/2012 | WO2011142618A3 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
03/01/2012 | WO2011140198A3 Compounds and methods of treating brain disorders |
03/01/2012 | WO2011139079A3 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration |
03/01/2012 | WO2011133661A3 Methods and compositions related to dopaminergic neuronal cells |
03/01/2012 | WO2011116355A3 Benzoisothiazolones as inhibitors of phosphomannose isomerase |
03/01/2012 | WO2011095801A3 Liquid pharmaceutical composition for buccal administration comprising morphine |
03/01/2012 | WO2011009193A8 Combinations of curcuminoids and mtor inhibitors for the treatment of tauopathies |
03/01/2012 | US20120053242 Compositions rich in omega-3 fatty acids with a low content in phytanic acid |
03/01/2012 | US20120053240 Method of Administering beta-hydroxy-beta-methylbutyrate (HMB) |
03/01/2012 | US20120053235 Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disorders |